PMC:7152526 / 1358-1659 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"47","span":{"begin":181,"end":189},"obj":"Species"},{"id":"53","span":{"begin":42,"end":58},"obj":"Disease"},{"id":"54","span":{"begin":76,"end":108},"obj":"Disease"},{"id":"55","span":{"begin":110,"end":114},"obj":"Disease"},{"id":"56","span":{"begin":123,"end":136},"obj":"Disease"}],"attributes":[{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D001102"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D018352"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D018352"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":17,"end":23},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T20","span":{"begin":42,"end":58},"obj":"Disease"},{"id":"T21","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T22","span":{"begin":117,"end":136},"obj":"Disease"},{"id":"T23","span":{"begin":140,"end":149},"obj":"Disease"},{"id":"T24","span":{"begin":146,"end":149},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0018695"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":17,"end":23},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T14","span":{"begin":123,"end":128},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":42,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T27","span":{"begin":17,"end":23},"obj":"UBERON:0001969"},{"id":"T28","span":{"begin":42,"end":47},"obj":"NCBITaxon:10239"},{"id":"T29","span":{"begin":70,"end":74},"obj":"SP_10"},{"id":"T30","span":{"begin":88,"end":99},"obj":"UBERON:0001004"},{"id":"T31","span":{"begin":110,"end":114},"obj":"SP_9"},{"id":"T32","span":{"begin":117,"end":128},"obj":"NCBITaxon:10376"},{"id":"T33","span":{"begin":140,"end":145},"obj":"NCBITaxon:8782"},{"id":"T99365","span":{"begin":17,"end":23},"obj":"UBERON:0001969"},{"id":"T77634","span":{"begin":42,"end":47},"obj":"NCBITaxon:10239"},{"id":"T59960","span":{"begin":70,"end":74},"obj":"SP_10"},{"id":"T84547","span":{"begin":88,"end":99},"obj":"UBERON:0001004"},{"id":"T71599","span":{"begin":110,"end":114},"obj":"SP_9"},{"id":"T80133","span":{"begin":117,"end":128},"obj":"NCBITaxon:10376"},{"id":"T77082","span":{"begin":140,"end":145},"obj":"NCBITaxon:8782"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}

{"project":"2_test","denotations":[{"id":"32281317-25030060-61647281","span":{"begin":247,"end":248},"obj":"25030060"},{"id":"32281317-26674811-61647282","span":{"begin":247,"end":249},"obj":"26674811"}],"text":" of convalescent plasma to treat emerging viral infections, including SARS, Middle East respiratory syndrome (MERS), Ebola virus disease or avian flu, can improve survival rates in patients whose condition worsens even with conventional treatment.12 However, the safety and efficacy of convalescent pl"}